Clinical Trial Update: A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 study of MTRX1011A in rheumatoid arthritis evaluating safety, pharmacokinetics, and pharmacodynamics was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MTRX1011A

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: TERMINATED